abstract |
The compounds of the invention are thienopyrimidine derivatives of the formula (I):wherein X is OR3 or NR3R4; q, R1, R2, R3, and R4 are described in the specification. These compounds are useful for the inhibiting the prolylpeptidase, inducing apoptosis and treating cancer. |